| Primary |
| Type 2 Diabetes Mellitus |
41.9% |
| Diabetes Mellitus |
36.0% |
| Hypertension |
9.0% |
| Depression |
1.4% |
| Hypercholesterolaemia |
1.2% |
| Diabetes Mellitus Inadequate Control |
0.9% |
| Blood Cholesterol |
0.9% |
| Blood Cholesterol Increased |
0.8% |
| Hypothyroidism |
0.8% |
| Pain |
0.8% |
| Blood Pressure |
0.7% |
| Coronary Artery Disease |
0.7% |
| Gastrooesophageal Reflux Disease |
0.7% |
| Hyperlipidaemia |
0.7% |
| Blood Glucose |
0.6% |
| Vitamin Supplementation |
0.6% |
| Anxiety |
0.6% |
| Atrial Fibrillation |
0.6% |
| Dyslipidaemia |
0.6% |
| Oedema |
0.6% |
|
| Pancreatitis |
13.4% |
| Rash |
11.6% |
| Drug Ineffective |
8.1% |
| Oedema Peripheral |
7.8% |
| Nausea |
7.2% |
| Blood Glucose Increased |
6.5% |
| Headache |
6.1% |
| Urticaria |
4.2% |
| Angioedema |
3.9% |
| Pancreatitis Acute |
3.9% |
| Vomiting |
3.9% |
| Diarrhoea |
3.0% |
| Hypoglycaemia |
3.0% |
| Dizziness |
2.8% |
| Oedema |
2.8% |
| Pruritus |
2.8% |
| Weight Increased |
2.5% |
| Urinary Tract Infection |
2.4% |
| Constipation |
2.2% |
| Medication Error |
2.2% |
|
| Secondary |
| Product Used For Unknown Indication |
36.9% |
| Type 2 Diabetes Mellitus |
25.6% |
| Diabetes Mellitus |
18.0% |
| Hypertension |
5.3% |
| Hyperlipidaemia |
2.0% |
| Blood Cholesterol Increased |
1.7% |
| Swelling |
1.5% |
| Chronic Obstructive Pulmonary Disease |
0.9% |
| Diabetes |
0.9% |
| Gastrooesophageal Reflux Disease |
0.9% |
| Blood Cholesterol Abnormal |
0.7% |
| Cardiac Failure Congestive |
0.7% |
| Prophylaxis |
0.7% |
| Rheumatoid Arthritis |
0.7% |
| Asthma |
0.6% |
| Blood Pressure |
0.6% |
| Erectile Dysfunction |
0.6% |
| Fluid Retention |
0.6% |
| Overweight |
0.6% |
| Sleep Disorder |
0.6% |
|
| Pancreatitis |
13.7% |
| Urticaria |
10.5% |
| Weight Decreased |
8.9% |
| Pancreatitis Acute |
8.1% |
| Vomiting |
8.1% |
| Glycosylated Haemoglobin Increased |
5.6% |
| Tubulointerstitial Nephritis |
4.8% |
| Acute Lymphocytic Leukaemia |
4.0% |
| Blood Glucose Increased |
4.0% |
| Dehydration |
4.0% |
| Fluid Retention |
4.0% |
| Renal Disorder |
4.0% |
| Hypogammaglobulinaemia |
3.2% |
| Weight Increased |
3.2% |
| Blood Glucose Decreased |
2.4% |
| Discomfort |
2.4% |
| Headache |
2.4% |
| Liver Disorder |
2.4% |
| Renal Failure |
2.4% |
| Anaemia |
1.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
40.9% |
| Diabetes Mellitus |
15.3% |
| Type 2 Diabetes Mellitus |
8.4% |
| Hypertension |
7.5% |
| Blood Cholesterol Increased |
4.7% |
| Rheumatoid Arthritis |
3.0% |
| Hepatitis C |
2.3% |
| Pain |
2.1% |
| Depression |
1.9% |
| Atrial Fibrillation |
1.6% |
| Prophylaxis |
1.5% |
| Drug Use For Unknown Indication |
1.5% |
| Cardiac Disorder |
1.4% |
| Gastrooesophageal Reflux Disease |
1.4% |
| Crohn's Disease |
1.2% |
| Psoriasis |
1.2% |
| Cardiac Failure Congestive |
1.1% |
| Anxiety |
1.0% |
| Osteoarthritis |
0.9% |
| Hypothyroidism |
0.9% |
|
| Weight Decreased |
8.9% |
| Blood Glucose Increased |
8.1% |
| Diarrhoea |
8.1% |
| Pruritus |
8.1% |
| Flushing |
7.4% |
| Renal Failure Acute |
5.9% |
| Nausea |
4.4% |
| Vision Blurred |
4.4% |
| Vomiting |
4.4% |
| Death |
3.7% |
| Fatigue |
3.7% |
| Glycosylated Haemoglobin Increased |
3.7% |
| Headache |
3.7% |
| Injection Site Pain |
3.7% |
| Pain |
3.7% |
| Pancreatitis |
3.7% |
| Urticaria |
3.7% |
| Weight Increased |
3.7% |
| Wrong Technique In Drug Usage Process |
3.7% |
| Back Disorder |
3.0% |
|
| Interacting |
| Diabetes Mellitus |
50.0% |
| Cardiac Disorder |
25.0% |
| Erectile Dysfunction |
25.0% |
|
| Drug Interaction |
25.0% |
| Hypogammaglobulinaemia |
25.0% |
| Pneumonia |
25.0% |
| Syncope |
25.0% |
|
